ZOMDF (Zomedica) Operating Margin %: -55.69% (As of Mar. 2026)


What is Zomedica Operating Margin %?

Zomedica ZOMDF -5.00% Operating Margin % is -55.69% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Zomedica ranks worse than 80.39% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Zomedica's Operating Income for the three months ended in Mar. 2026 was $-4.90 Mil. Zomedica's Revenue for the three months ended in Mar. 2026 was $8.80 Mil. Therefore, Zomedica's Operating Margin % for the quarter that ended in Mar. 2026 was -55.69%.

The historical rank and industry rank for Zomedica's Operating Margin % or its related term are showing as below:

ZOMDF' s Operating Margin % Range Over the Past 10 Years
Min: -517.15   Med: -125.43   Max: -71.97
Current: -71.97


ZOMDF's Operating Margin % is ranked worse than
80.39% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs ZOMDF: -71.97

Zomedica's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Zomedica's Operating Income for the three months ended in Mar. 2026 was $-4.90 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $-24.71 Mil.


Zomedica  (OTCPK:ZOMDF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Zomedica Operating Margin % Related Terms


Zomedica Operating Margin % Historical Data

* Premium members only.

The historical data trend for Zomedica's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zomedica Operating Margin % Chart

Zomedica Annual Data
Trend Feb16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -517.15 -115.81 -125.43 -128.38 -89.04

Zomedica Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -134.08 -115.38 -81.61 -49.32 -55.69

ZOMDF vs RPID, STIM, OM: Operating Margin % Comparison

For the Medical Devices subindustry, Zomedica's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zomedica Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zomedica's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Zomedica's Operating Margin % falls into.



Zomedica Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Zomedica's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-28.52 / 32.03
=-89.04 %

Zomedica's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-4.9 / 8.799
=-55.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -55.69% mean?
Zomedica (ZOMDF) has a Operating Margin % of -55.69% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Zomedica and its competitors. According to the industry distribution chart, Zomedica ranks #656 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 80.4%.
Is Zomedica's Operating Margin % too high?
Zomedica's current Operating Margin % is -55.69%. Based on the distribution chart, Zomedica ranks #656 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Zomedica's Operating Margin % compare to RPID and STIM?
According to the Medical Devices & Instruments industry distribution chart, Zomedica ranks #656 out of 816 companies for Operating Margin %. This places Zomedica in the lower half of its industry. The industry median Operating Margin % is 3.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Zomedica and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zomedica's current Operating Margin % is -55.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zomedica stock overvalued right now?
Based on GuruFocus' analysis, Zomedica (ZOMDF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.19, compared to a current price of $0.10 — trading 50% below its estimated fair value. The current Operating Margin % is -55.69%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Zomedica (ZOMDF), the current Operating Margin % is -55.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zomedica Business Description

Address 1101 Technology Drive, Suite 100, Ann Arbor, MI, USA, 48108
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its segments consist of Diagnostics, Therapeutic Devices, and Development Services. It earns the majority of revenue from the therapeutics segment, which consists of Assisi, PulseVet, and VETIGEL products.